OKYO Pharma Ltd (OKYO) insider trading.
In Q3 2026, insiders at OKYO Pharma Ltd reported 14 non-derivative transactions on 15 Forms 3, 4 and 5: 7 open-market purchases worth $136K and 0 sales.
- Transactions
- 14
- Purchases (P)
- 7
- Sales (S)
- 0
- Net shares, P minus S
- 94,363
- Insiders
- 6
- Last filed
- 2026-08-07
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Cerrone Gabriele M | Director, TenPercentOwner | 4 | 2 | 0 |
| Patil Rajkumar V. | Officer · Chief Scientific Officer | 2 | 1 | 0 |
| Dempsey Robert John | Director, Officer · CHIEF EXECUTIVE OFFICER | 2 | 1 | 0 |
| Mantelli Flavio | Officer · CHIEF MEDICAL OFFICER | 2 | 1 | 0 |
| Jacob Gary S | Director, Officer · CHIEF DEVELOPMENT OFFICER | 2 | 1 | 0 |
| Brancaccio John P | Director | 2 | 1 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-27 | Patil Rajkumar V. | P (A) | 3,363 | $1.49 | 20,030 | Form 4/A |
| 2026-07-27 | Patil Rajkumar V. | A (A) | 3,363 | $1.49 | 20,030 | Form 4 |
| 2026-07-22 | Dempsey Robert John | P (A) | 15,000 | $1.54 | 15,000 | Form 4/A |
| 2026-07-22 | Dempsey Robert John | A (A) | 15,000 | $1.54 | 15,000 | Form 4 |
| 2026-07-21 | Cerrone Gabriele M | P (A) | 22,500 | $1.45 | 10,873,916 | Form 4/A |
| 2026-07-21 | Mantelli Flavio | P (A) | 20,000 | $1.4 | 20,000 | Form 4/A |
| 2026-07-21 | Jacob Gary S | P (A) | 3,500 | $1.4 | 112,420 | Form 4/A |
| 2026-07-21 | Brancaccio John P | P (A) | 5,000 | $1.48 | 35,201 | Form 4/A |
| 2026-07-21 | Brancaccio John P | A (A) | 5,000 | $1.48 | 35,201 | Form 4 |
| 2026-07-21 | Jacob Gary S | A (A) | 3,500 | $1.4 | 112,420 | Form 4 |
| 2026-07-21 | Cerrone Gabriele M | A (A) | 22,500 | $1.45 | 10,873,916 | Form 4 |
| 2026-07-21 | Mantelli Flavio | A (A) | 20,000 | $1.4 | 20,000 | Form 4 |
| 2026-07-20 | Cerrone Gabriele M | P (A) | 25,000 | $1.4 | 10,851,416 | Form 4/A |
| 2026-07-20 | Cerrone Gabriele M | A (A) | 25,000 | $1.4 | 10,851,416 | Form 4 |
Transaction codes in this quarter
Get OKYO insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1849296&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · OKYO company page · OKYO Pharma Ltd on SEC.gov
Questions
Are insiders buying or selling OKYO Pharma Ltd (OKYO)?
In Q3 2026, insiders at OKYO Pharma Ltd reported 14 non-derivative transactions on 15 Forms 3, 4 and 5: 7 open-market purchases worth $136K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these OKYO Pharma Ltd insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/okyo.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.